Re/code: "With WHO Data, TrialReach Looks to Democratize the Clinical Trial"

TrialReach announced a new relationship that will allow even more patients to access clinical trials. Re/code reported:

"The five-year-old London startup developed a central database that provides patients with free access to a growing number of clinical trials around the world, as well as simplified explanations of inclusion requirements. The company told Re/code it just formed a relationship with the World Health Organization that will bring the number of trials on the site to 270,000, more than triple the number today.

'We’ll become effectively the biggest source for clinical trials that’s ever existed, on or offline,' said Pablo Graiver, chief executive of TrialReach, in an interview."

Read more on Re/code.